LatticePoint

About LatticePoint

LatticePoint is a boutique consulting firm that focuses on pricing and market access for innovative medicines and medical devices. LatticePoint is led by former industry market access leaders who understand how to plan for the political, scientific, and financial realities that will be pivotal in negotiating product access. We work with biopharma companies and investors to help define, negotiate, and defend the value of their products in key markets around the world. The LatticePoint team has over 40 years of pharmaceutical and biotechnology industry experience. Led by former industry market access leaders and a high-caliber team with significant experience in the sciences, licensing, M&A due diligence and integration, venture capital and international affiliate operations, we have a depth of experience not seen in most consultancies. We can efficiently and accurately define a medicine’s value; and have our team ready to create the right strategy whether you are raising capital, in-licensing, launching or preparing for competition. At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, hospitals, HTA bodies and EMA for early access, give feedback on clinical program design, and create and execute in-country reimbursement strategy negotiations in key markets around the world. We retain a Global Payer Panel for market research interviews.

View contact profiles from LatticePoint